Literature DB >> 11546883

Chlamydia pneumoniae in atherosclerotic middle cerebral artery.

D Virok1, Z Kis, L Karai, L Intzedy, K Burian, A Szabo, B Ivanyi, E Gonczol.   

Abstract

BACKGROUND AND
PURPOSE: Atherosclerotic middle cerebral arteries are frequent sites of thrombosis, leading to stroke. Previous studies have suggested a role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis. However, the presence of this pathogen in atherosclerotic middle cerebral arteries has heretofore not been documented. In the present study, we analyzed atheromatous plaques from middle cerebral arteries for the presence of C pneumoniae.
METHODS: Atherosclerotic middle cerebral arteries from 15 cadavers who died of natural causes and corresponding nonatherosclerotic arteries from 4 otherwise healthy trauma victims were examined. Assays for C pneumoniae DNA were carried out by nested polymerase chain reaction (nPCR) specific for the C pneumoniae ompA gene. The presence of the bacterium was assessed by transmission electron microscopy.
RESULTS: Five of the 15 atherosclerotic arterial samples and none of the control tissues were positive for C pneumoniae by nPCR. Particles similar in morphology and size to C pneumoniae elementary bodies were detected by transmission electron microscopy in 4 of the 5 nPCR-positive atherosclerotic samples.
CONCLUSIONS: The demonstration of C pneumoniae in atherosclerotic middle cerebral arteries is consistent with the hypothesis that this bacterium is involved in acute and chronic cerebrovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11546883     DOI: 10.1161/hs0901.094290

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

Review 1.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study.

Authors:  Søren P Johnsen; Kim Overvad; Lars Ostergaard; Anne Tjønneland; Steen E Husted; Henrik T Sørensen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Inflammatory mechanisms of stroke.

Authors:  Mitchell S V Elkind
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

4.  Chlamydia pneumoniae and Cardiovascular Disease.

Authors:  Maria Kolia; Ignatius William Fong
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

5.  Association between Chlamydia pneumoniae IgG antibodies and migraine.

Authors:  QiHong Lu; Jinzh Xu; HongYan Liu
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

Review 6.  Infectious burden: a new risk factor and treatment target for atherosclerosis.

Authors:  Mitchell S V Elkind
Journal:  Infect Disord Drug Targets       Date:  2010-04

7.  Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study.

Authors:  Soo Chan Carusone; Marek Smieja; William Molloy; Charlie H Goldsmith; Jim Mahony; Max Chernesky; Judy Gnarpe; Tim Standish; Stephanie Smith; Mark Loeb
Journal:  BMC Neurol       Date:  2004-10-12       Impact factor: 2.474

8.  Limited role for C. pneumoniae, CMV and HSV-1 in cerebral large and small vessel atherosclerosis.

Authors:  M Voorend; A J A M van der Ven; B Kubat; J Lodder; C A Bruggeman
Journal:  Open Neurol J       Date:  2008-07-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.